Showing results (1061-1070 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|June 18, 2017
Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-AnalysisKatsiaryna Bykov, Sebastian Schneeweiss, Robert J Glynn, et al.
Drug Safety|September 1, 1993
Antiepileptic drugs. A review of clinically significant drug interactionsP N Patsalos, J S Duncan
Drug Safety|September 1, 1993
Cancer therapy and oral mucositis. An appraisal of drug prophylaxisC J Verdi
Drug Safety|September 1, 1993
Clinically important ocular reactions to systemic drug therapyI G Rennie
Drug Safety|October 1, 1993
Continuous versus intermittent sulphonylurea therapy in non-insulin-dependent diabetes mellitusG Grunberger
Drug Safety|October 1, 1993
Epidemiology of drug overdose in childrenA D Woolf, F H Lovejoy
Drug Safety|January 20, 2010
Benefit-risk assessment of exenatide in the therapy of type 2 diabetes mellitusBaptist Gallwitz
Drug Safety|January 20, 2010
Antipsychotic-induced hyponatraemia: a systematic review of the published evidenceDidier Meulendijks, Cyndie K Mannesse, Paul A F Jansen, et al.
Drug Safety|January 20, 2010
Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profilesSteven Bailey, Ajay Singh, Robert Azadian, et al.
Drug Safety|April 30, 2017
Detecting Signals of Disproportionate Reporting from Singapore's Spontaneous Adverse Event Reporting System: An Application of the Sequential Probability Ratio TestCheng Leng Chan, Sowmya Rudrappa, Pei San Ang, et al.
Pageof 309